| 000 | 01481 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512040508.0 | ||
| 264 | 0 | _c19881031 | |
| 008 | 198810s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/BF00615217 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMassey, K L | |
| 245 | 0 | 0 |
_aDuration of protection of calcium channel blockers against exercise-induced bronchospasm: comparison of oral diltiazem and inhaled gallopamil. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _c1988 |
||
| 300 |
_a555-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aAsthma, Exercise-Induced _xdrug therapy |
| 650 | 0 | 4 |
_aDiltiazem _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aForced Expiratory Flow Rates |
| 650 | 0 | 4 | _aForced Expiratory Volume |
| 650 | 0 | 4 |
_aGallopamil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aVital Capacity |
| 700 | 1 | _aHarman, E | |
| 700 | 1 | _aHendeles, L | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 34 _gno. 6 _gp. 555-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00615217 _zAvailable from publisher's website |
| 999 |
_c3174894 _d3174894 |
||